ARYA Sciences Acquisition Corp IV
ARYD · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$0 | $0 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$0 | $0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.22 | 0.16 | -0.4 | -0.001 |
| % Growth | -237.5% | 140% | -57,042.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |